Championing human health through precision drug discovery

Building cutting-edge platforms for discovery

Training the next generation of scientific leaders

Pioneering research, treatments and diagnostics

Bringing innovations from the lab to society

Unlocking the Power of Proteins

Chemistry of Life Processes Institute (CLP) at Northwestern University is pioneering the greatest wave of biomedical innovation since the Human Genome Project opened the door for individualized medicine two decades ago. Known as proteomics, this fast-growing field identifies and measures the various forms of proteins (proteoforms) that link genes and disease in order to diagnose and treat threats to human health.

CLP houses the premier center for proteomics under the leadership of Neil Kelleher, a leading advocate for the Human Proteoform Project, a global initiative to map all proteins in the human body. Leveraging an unsurpassed capability to analyze proteins, the Institute is ready to launch the next era of precision medicine by discovering the changes in proteoforms that cause disease, creating sensitive diagnostics to catch disease early and prevent organ damage, and identifying new, proteoform-enabled targets for drug development and delivery.

Through its Convergence Research Initiatives, CLP assembles world-class teams of Northwestern chemists, clinicians, life scientists and engineers to transform how we diagnose, treat and, someday, cure devasting diseases that have eluded effective treatments, including liver and pancreatic cancers, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

Training the Next Generation of Scientists

CLP’s world-class research and training programs prepare Northwestern undergraduates and graduate students to tackle tomorrow’s biggest biomedical challenges. Students and trainees are required to work with two mentors from different disciplines to learn multiple languages of scientific inquiry. Our curricula emphasize skills development, rigor, reproducibility and hands-on training across a broad spectrum of instruments and methods.

Together with our partners across the University, Northwestern Medicine, and Lurie Cancer Center, we pioneer new science and hasten the delivery of life-changing innovations to society.

 

“At CLP, mapping the universe of human proteins is already underway, and with donor support, we’ll be able to accelerate the ability to detect human disease earlier and develop precision medicines. We’re powering drug development with truly next generation proteomics.”

Neil L. Kelleher, PhD | Director of CLP

Chip
DISCOVER OUR IMPACT
Chip
EXPAND YOUR SKILLS
Chip
EXPLORE OUR RESOURCES
Chip
TRANSLATE YOUR RESEARCH

BY THE NUMBERS

INVESTING IN INNOVATION

$1.2M Invested in CLP Institute seed projects

$24M New external funding resulting from seed grants

IN THE PIPELINE

35 New drug candidates

31 Medical devices

9 Diagnostic technologies

BENCH TO SOCIETY

33 New companies spun out by Institute faculty

$2.5B External investments in new companies

Read All News

Student Spotlight: Ananya Basu

Student Spotlight: Ananya Basu

Ananya Basu, a third-year PhD student, is using innovative approaches to overcome previously intractable targets in the Zhang Lab. Appointed to the CLP Predoctoral Training Program, she is being co-mentored by Zhang (chemistry) and Horvath (molecular biosciences)....

Transfer learning paves the way for new disease treatments

Transfer learning paves the way for new disease treatments

Technological advances in gene sequencing and computing have led to an explosion in the availability of bioinformatic data and processing power, respectively, creating a ripe nexus for artificial intelligence (AI) to design strategies for controlling cell behavior. In...